LysoPC(22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
|
Basic information |
| Metabolite name | LysoPC(22:5(7Z,10Z,13Z,16Z,19Z)/0:0) |
 | HMDB0010403 |
 |
C04230 |
 |
53480475 |
| Synonyms | LysoPC(22:5(7Z,10Z,13Z,16Z,19Z)) |
| No. of studies | 3 |
|
Basic information |
| Metabolite name | LysoPC(22:5(7Z,10Z,13Z,16Z,19Z)/0:0) |
| HMDB0010403 |
|
C04230 |
|
53480475 |
| Synonyms | LysoPC(22:5(7Z,10Z,13Z,16Z,19Z)) |
| No. of studies | 3 |
|
Relationship between LysoPC(22:5(7Z,10Z,13Z,16Z,19Z)/0:0) and depression (count: 3) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M691 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M835 | Type1 | CRS group vs. control group | Faece | C57BL/6 mouse | Up |
| Study M918 | Type1 | methamphetamine group vs. control group | Serum | C57BL/6 mouse | Down |